Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People who have been diagnosed with rheumatoid arthritis according to recognised international diagnostic standards (1987 ACR or 2010 ACR/EULAR criteria)
- People whose rheumatoid arthritis also meets a specific Traditional Chinese Medicine diagnosis involving kidney deficiency and blocked channels (confirm with trial site)
- People whose rheumatoid arthritis disease activity falls within a specific low-to-moderate range, measured by a scoring system called DAS28 (a score between 2.6 and 3.2)
- People who have been regularly taking methotrexate (7.5–15 mg once weekly) and tofacitinib (5 mg twice daily) on a stable, unchanged schedule for more than 4 weeks before joining
- People who are willing to take part and have signed a written consent form
Who may not be able to join:
- People who have taken immune-suppressing medications other than certain standard rheumatoid arthritis drugs (such as hydroxychloroquine, methotrexate, sulfasalazine, or leflunomide) in the 3 months before joining
- People who have had an organ transplant, have cancer, or have significant problems with the heart, brain, liver, kidneys, blood, or other major organs
- People who have certain mental health conditions (such as cognitive disorders, depression, or anxiety), or certain neurological conditions affecting the brain, spinal cord, or nerves (such as epilepsy, stroke, multiple sclerosis-related conditions, or restless legs syndrome)
- People who are pregnant, breastfeeding, or planning a pregnancy within the next 6 months, as well as people of childbearing age who are unable or unwilling to use adequate contraception during the trial and for one month after the last dose (this applies to both the participant and their partner)
- People with a Body Mass Index (BMI) over 35, people who are allergic to the study medication, or people already participating in another clinical trial
- People the trial investigators consider unsuitable for other reasons, such as those who live too far away to attend follow-up visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618810902100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
DAS28
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.